I have always believed that science, technology, the work that many of you are doing, is the work of the 21st century, 22nd century, and it is a job creator.
Summer Lee
The Public Record
Summer Lynn Lee is a Democratic member of the Pennsylvania House of Representatives, representing the 34th District since January 1, 2019. She is known for her strong advocacy on social justice issues and her commitment to community engagement. Lee has focused on policies that address inequality and promote the interests of her constituents, often emphasizing the need for accountability among elected officials and the importance of fighting against corporate influence in politics. Her work reflects a dedication to progressive values and grassroots activism.
I think this is crucial in terms of what happened to Senator Stevens. And in his death, I apologize for what happened.
If we make a commitment we have to show that we are willing to stay in Africa.
I don't want to misspeak again, but that this bill could be marked up by Foreign Affairs.
Our message should be that this vehicle of H.R. 4221 should be establishing that partnership of exports.
Absolutely. There are 800 million-plus and growing. There may be 1 billion soon, and there are 53 nation-states.
I would just say the Congressional Black Caucus, and I am not sure if that kind of give and take has occurred.
Africa is an adult, is worthy of the respect from the United States as an equal partner in trade, in defense, in issues of health care and respect of culture.
Africa is an adult and should be treated as such and we should be increasingly looking to send mature delegations over joined with Members of Congress.
I want to begin by thanking Congresswoman Jackson Lee and Congressmen McCaul and Cuellar for their support in our fight to keep the C-130s at the 136th Airlift Wing in Ft.
I would say, since this is the first time, Congresswoman and Congressman Smith, that I have been at this table since the loss of our dear champion, I know that he is looking well at these hearings that you are holding.
But, in terms of your actual evaluation of Express Scripts-Medco merger, but other actions by these companies, many of them we know their names, who are PBMs, can't you initiate a review or an evaluation as to whether there is any…
If we tried to glean all of the information, would you be able to provide data?
I think they have a valuable role, even as a small business, but as a familiar face to the community.
I believe that what we tried to do in the Affordable Care Act, close the doughnut hole, keep people alive who have preexisting diseases is a good thing.
Because, Mr. James, I wanted to ask, the regulator, he has to follow the law. How do you answer the question of higher costs?





